Cargando…
Clinical review: Corticotherapy in sepsis
The use of glucocorticoids (corticotherapy) in severe sepsis is one of the main controversial issues in critical care medicine. These agents were commonly used to treat sepsis until the end of the 1980s, when several randomized trials casted serious doubt on any benefit from high-dose glucocorticoid...
Autores principales: | Prigent, Helene, Maxime, Virginie, Annane, Djillali |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC420022/ https://www.ncbi.nlm.nih.gov/pubmed/15025773 http://dx.doi.org/10.1186/cc2374 |
Ejemplares similares
-
Science review: Mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids
por: Prigent, Hélène, et al.
Publicado: (2004) -
Precision medicine for corticotherapy in COVID-19
por: Annane, Djillali, et al.
Publicado: (2022) -
Year in review 2013: Critical Care – sepsis
por: de Montmollin, Etienne, et al.
Publicado: (2014) -
Corticosteroids for severe sepsis: an evidence-based guide for physicians
por: Annane, Djillali
Publicado: (2011) -
Year in review 2010: Critical Care - multiple organ dysfunction and sepsis
por: de Montmollin, Etienne, et al.
Publicado: (2011)